“For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law. According to a just published review in the German scientific journal Deutsches Ärzteblatt International, scientific findings from over 100 controlled clinical trials involving either cannabis or its constituents provide ‘clear evidence that cannabinoids are useful for the treatment of various medical conditions.'”
Related posts:
Florida Bill Would Make it a Crime to be the Victim of Auto Theft
Mom Calls Cops After Discovering Son, 15, Was Watching Porn
Private Probation Firm Illegally Extended Sentences, Judge Finds
Bitcoin Price Could Reach $98,500, Say Wall Street Analysts
New Bill Would Outlaw Warrantless Border Phone Searches Of U.S. Citizens
NDAA Indefinite Detention Reinstated by Appeals Court
Falling Real Yields: A Buy Signal for Gold
US Airspace To Crawl With 7,500 Drones In 5 Years
Move over NSA, here comes the Obamacare Big Brother database
What Is Hemp Plastic
Make Your Own 3-D Printer for $100
Dubai’s gold trade waits on India windfall
If It’s Not About The Money . . .
Leaked Sony ad for QX10 and QX100 lens cameras
Where the World's Unsold Cars Go To Die